Roshan Rahnama Joins Avalere Health as Executive Vice President to Enhance Market Access Strategies
Avalere Health has announced a significant addition to its leadership team with the appointment of Roshan Rahnama as Executive Vice President. This strategic hire is set to enhance Avalere's innovative market access marketing services, aiming to streamline healthcare access for various patient populations.
Rahnama brings over 20 years of comprehensive experience from her previous roles as a healthcare strategist and business leader. Her extensive background includes working on the commercialization of treatments for both communicable and non-communicable diseases across multiple healthcare sectors, influencing areas such as payer, provider, and caregiver interactions. Rahnama's focus on person-centered care is a fundamental component of her approach, underscoring her commitment to removing barriers that prevent patient access to essential healthcare services.
The U.S. President of Policy, Access, Value, and Evidence, Sarah Alwardt, emphasized that navigating patient access involves much more than just traditional payer formulary placements. “Roshan will lead Avalere Health’s new service offering to develop data-driven, agile strategies that evolve as the healthcare landscape changes,” she stated, highlighting the company's commitment to bridging gaps in the patient care journey. The insights driven from Avalere's extensive data capabilities will play a critical role in shaping actionable strategies tailored to the nuances of the healthcare ecosystem.
Rahnama shared her vision for market access, stating, “We have an opportunity to truly level up what market access means — the ability to get the right medicine to the right person at the right time and at the right price.” She stressed the importance of addressing factors beyond the clinical aspects, such as health inequities and geographical barriers, that influence disease manifestation. This holistic view not only enhances patient experiences but also allows brands to unlock new avenues for value and competitive differentiation within the market.
Amar Urhekar, the COO of Avalere Health, reiterated the importance of access in healthcare and how it has historically been a significant barrier. He noted, “Our market access marketing offering is a fantastic example of how our teams unite across the product lifecycle, innovating with agility to reach more patients.” It’s evident that under Rahnama's leadership, Avalere Health is poised to redefine its market access strategies significantly.
Having served various stakeholders, including biopharmaceutical companies and health systems, Rahnama’s role will be pivotal in developing innovative solutions that defy conventional approaches, ultimately ensuring that essential care reaches every individual in need.
Avalere Health is recognized as a crucial partner for companies navigating the evolving healthcare landscape since its formation in 2001. The organization brings together over 1,500 experts in consulting, medical policy, marketing, and technology to foster a collaborative environment aimed at improving health outcomes and enhancing patient access.
In conclusion, Roshan Rahnama’s appointment at Avalere Health represents a pivotal moment for the organization and the broader healthcare community. With her wealth of experience and commitment to innovative access strategies, Avalere is set to accelerate its mission of making life-changing therapies accessible to all, particularly for those facing systemic barriers in their pursuit of health equity. As the healthcare ecosystem continues to evolve, Rahnama’s leadership is expected to bring fresh insights and actionable solutions that will benefit stakeholders across the board.
Rahnama brings over 20 years of comprehensive experience from her previous roles as a healthcare strategist and business leader. Her extensive background includes working on the commercialization of treatments for both communicable and non-communicable diseases across multiple healthcare sectors, influencing areas such as payer, provider, and caregiver interactions. Rahnama's focus on person-centered care is a fundamental component of her approach, underscoring her commitment to removing barriers that prevent patient access to essential healthcare services.
The U.S. President of Policy, Access, Value, and Evidence, Sarah Alwardt, emphasized that navigating patient access involves much more than just traditional payer formulary placements. “Roshan will lead Avalere Health’s new service offering to develop data-driven, agile strategies that evolve as the healthcare landscape changes,” she stated, highlighting the company's commitment to bridging gaps in the patient care journey. The insights driven from Avalere's extensive data capabilities will play a critical role in shaping actionable strategies tailored to the nuances of the healthcare ecosystem.
Rahnama shared her vision for market access, stating, “We have an opportunity to truly level up what market access means — the ability to get the right medicine to the right person at the right time and at the right price.” She stressed the importance of addressing factors beyond the clinical aspects, such as health inequities and geographical barriers, that influence disease manifestation. This holistic view not only enhances patient experiences but also allows brands to unlock new avenues for value and competitive differentiation within the market.
Amar Urhekar, the COO of Avalere Health, reiterated the importance of access in healthcare and how it has historically been a significant barrier. He noted, “Our market access marketing offering is a fantastic example of how our teams unite across the product lifecycle, innovating with agility to reach more patients.” It’s evident that under Rahnama's leadership, Avalere Health is poised to redefine its market access strategies significantly.
Having served various stakeholders, including biopharmaceutical companies and health systems, Rahnama’s role will be pivotal in developing innovative solutions that defy conventional approaches, ultimately ensuring that essential care reaches every individual in need.
Avalere Health is recognized as a crucial partner for companies navigating the evolving healthcare landscape since its formation in 2001. The organization brings together over 1,500 experts in consulting, medical policy, marketing, and technology to foster a collaborative environment aimed at improving health outcomes and enhancing patient access.
In conclusion, Roshan Rahnama’s appointment at Avalere Health represents a pivotal moment for the organization and the broader healthcare community. With her wealth of experience and commitment to innovative access strategies, Avalere is set to accelerate its mission of making life-changing therapies accessible to all, particularly for those facing systemic barriers in their pursuit of health equity. As the healthcare ecosystem continues to evolve, Rahnama’s leadership is expected to bring fresh insights and actionable solutions that will benefit stakeholders across the board.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.